Drug Development for Maternal Health Cannot Be Left to the Whims of the Market

1. WhiteNJMcGreadyRMNostenFH

2008

New medicines for tropical diseases in pregnancy: Catch-22.

PLoS Med

5

e133

doi:10.1371/journal.pmed.0050133

2. FiskNMAtunR

2008

Market failure and the poverty of new drugs in maternal health.

PLoS Med

5

e22

doi:10.1371/journal.pmed.0050022

3. MenéndezCRomagosaCIsmailMRCarrilhoCSauteF

2008

An autopsy study of maternal mortality in Mozambique: The contribution of infectious diseases.

PLoS Med

5

e44

doi:10.1371/journal.pmed.0050044

4. OzgedizDRivielloR

2008

The “other” neglected diseases in global public health: Surgical conditions in sub-Saharan Africa.

PLoS Med

5

e121

doi:10.1371/journal.pmed.0050121

5. World Health Organization

2007

Maternal mortality in 2005: Estimates developed by WHO, UNICEF, UNFPA and The World Bank.

Available: http://www.who.int/reproductivehealth/publications/maternal_mortality_2005/mme_2005.pdf. Accessed 22 May 2008

6. United Nations

2008

The UN Millennium Development Goals.

Available: http://www.un.org/millenniumgoals/. Accessed 22 May 2008

7. KenyonSDixon-WoodsMJacksonCJWindridgeKPitchforthE

2006

Participating in a trial in a critical situation: A qualitative study in pregnancy.

Qual Saf Health Care

15

98

101

doi:10.1136/qshc.2005.015636

8. HubbardTLoveJ

2004

A new trade framework for global healthcare R&D.

PLoS Biol

2

e52

doi:10.1371/journal.pbio.0020052